The Challenge of Change - Managing Excipients Control
Colorcon
11-May-2005 - Researchers in the US have developed a way to make large, protein-based drugs suitable for oral rather than injectable delivery by fusing them with a carrier molecule, reports Phil Taylor.
11-May-2005 - French chemicals company Rhodia, already facing two separate investigations for alleged accounting irregularities and insider trading, has become embroiled in further legal fights just as it starts to lift itself out of financial difficulties.
11-May-2005 - Medarex has announced the initiation of a phase I clinical trial of its human monoclonal antibody for the treatment of ulcerative colitis after the FDA granted the company an Investigational New Drug (IND) application.
09-May-2005 - Roquette has introduced pyrogen-free versions of its sodium lactate and sodium gluconate products for applications in the pharmaceuticals industry, reports Phil Taylor.
09-May-2005 - US researchers think they have found promising new molecular targets and treatment approaches for malignant brain tumours, suggesting a new therapy for anti-cancer drugs.
09-May-2005 - A new laboratory technique used by fruit fly geneticists for more than a decade is now available to scientists studying genes and diseases in mice. This technique offers a powerful new tool to study genetics, particularly in disease.
09-May-2005 - Italy's fine chemicals industry organisation, Afaquim, is organising a conference in September aimed at coordinating the efforts of European active pharmaceutical ingredient (API) suppliers in the face of increasing competition from the Far East.
04-May-2005 - Teva Pharmaceutical Industries' active pharmaceutical ingredients (API) business is on track to become a $1 billion enterprise this year, although growth in the first quarter of this year was almost entirely from in-house sales, reports Phil Taylor.
04-May-2005 - Canadian company Generex Biotechnology has stolen a march on its larger rivals in the pharmaceutical industry by winning regulatory approval for the world's first non-injectable insulin formulation, reports Phil Taylor.
03-May-2005 - Patients suffering from conditions as diverse as asthma and diabetes could benefit from research at Cardiff University to improve the effectiveness of drugs taken through spray inhalers.
03-May-2005 - UK-based contract researcher Synprotec has been acquired by India's Dishman Pharmaceuticals & Chemicals in a move that marks a continuing expansion of the latter firm into foreign markets, reports Phil Taylor.
02-May-2005 - Lonza is planning a major exansion of its peptides manufacturing capacities at Visp, Switzerland, in response to what it said was 'the increased demand for peptide active pharmaceutical ingredients worldwide'.
02-May-2005 - German drug development company BioGenerix has earmarked up to $61.5 million (€48m) to develop a new version of an already-marketed biologic drug using a pegylation technology developed by US firm Neose, reports Phil Taylor.
29-Apr-2005 - Cytopia has received the green light to trial a promising new drug that could prove effective in the fight against advanced solid tumours. In animal studies, the drug candidate has already shown efficacy in killing cancer cells in prostate, colon and breast cancer.
29-Apr-2005 - University of Toronto researchers have developed a new chemical reaction that could greatly accelerate pharmaceutical production, while also cutting costs and toxic by-products.
28-Apr-2005 - Antares Pharma has announced that it has completed formulation and preclinical activities for its first fast melt oral tablet incorporating a nonsteroidal anti-inflammatory drug (NSAID) using its Easy Tec fast melt technology.
28-Apr-2005 - BioGenex announces the launch of the Xmatrx, a walk-away system that automates molecular diagnostics and drug target identification and validation. The system is specifically designed to enable drug discovery companies to customise applications with high throughput, continuous access and total flexibility.
27-Apr-2005 - Bentley Pharmaceuticals has entered into an agreement with Dong Sung Pharmaceuticals for the development of an intranasal spray formulation of insulin for the South Korean market with the view of extending this deal into additional territories.
27-Apr-2005 - Cambridge Major has announced that it has selected a new low-temperature fluid, which has proven to be suitable for single-fluid heating and cooling systems, making it appropriate to meet the needs of the pharmaceutical industry.
26-Apr-2005 - A recently-launched project by the European Union is aiming to demonstrate once and for all whether nanoparticles - which underpin the emerging discipline of nanotechnology - are safe, reports Phil Taylor.
20-Apr-2005 - SkyePharma will shortly sign up a marketing partner for its improved formulation of the local anaesthetic bupivacaine, a product which the UK-based drug delivery company says is one of the most important products in its pipeline.
20-Apr-2005 - Researchers at Harvard University in the US have developed a new way of synthesising tetracyclines, potentially opening up avenues to the development of new drugs in this valuable antibiotic class, writes Phil Taylor.
20-Apr-2005 - Canadian researchers have a developed a new chemical reaction that could greatly accelerate pharmaceutical production, while also cutting costs and toxic by-products.
19-Apr-2005 - Water soluble film specialist MonoSolRx has been granted a process patent in Ireland covering its edible film strips, an emerging dosage form for the oral delivery of drugs and nutritonal products.
19-Apr-2005 - Solutia has elected to retain its Pharmaceutical Services Division (PSD) despite suggestions that a spin out or sale of the business were being considered, reports Phil Taylor.